Hims & Hers Health Inc. buy Needham & Company LLC
Start price
06.05.25
/
50%
€34.47
Target price
06.05.26
€54.01
Performance (%)
-18.25%
Price
11:21
€28.18
Summary
This prediction is currently active. The prediction for Hims & Hers Health Inc. disappoints with a performance of -18.25%. This prediction currently runs until 06.05.26. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Hims & Hers Health Inc. | -6.480% | -6.480% |
| iShares Core DAX® | 2.331% | 5.140% |
| iShares Nasdaq 100 | 2.077% | 2.956% |
| iShares Nikkei 225® | 2.759% | 7.214% |
| iShares S&P 500 | 1.613% | 2.893% |
Comments by Needham___Company_LL for this prediction
In the thread Hims & Hers Health Inc. diskutieren
Hims & Hers Health, Inc. (NYSE: HIMS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $61.00 price target on the stock.
Ratings data for HIMS provided by MarketBeat
Stopped prediction by Needham___Company_LL for Hims & Hers Health Inc.
Hims & Hers Health Inc.
Start price
Target price
Perf. (%)
€48.75
04.06.25
04.06.25
€57.08
04.06.26
04.06.26
-42.22%
11:21
11:21
Hims & Hers Health Inc.
Start price
Target price
Perf. (%)
€38.14
25.02.25
25.02.25
€58.08
25.02.26
25.02.26
-26.11%
11:21
11:21
Hims & Hers Health Inc.
Start price
Target price
Perf. (%)
€26.43
06.01.25
06.01.25
€29.74
06.01.26
06.01.26
14.30%
07.01.26
07.01.26
Hims & Hers Health Inc.
Start price
Target price
Perf. (%)
€15.69
22.08.24
22.08.24
€21.54
22.08.25
22.08.25
145.06%
23.08.25
23.08.25